Bought back in recently as the next wave up approaches. Massive space Alzheimer's Dementia and ACW with a great team at both board level and scientifically have the potential with Xanamem to unlock serious value and gains for shareholders here as well as sufferers in this space. Growing evidence suggests excess cortisol levels are associated with brain changes leading to cognitive decline and Xanamen targets the enzyme 11-HSD1 which blocks the production of excess cortisol. ACW i believe is now about to take the next wave up after sitting dormant for many months. With a price target of 35c by Baker Young these levels are a very good buying opportunity.
Looking Strong, page-40
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $206.0M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 24515 | 8.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.0¢ | 82424 | 1 |
View Market Depth
| Last trade - 16.16pm 09/08/2024 (20 minute delay) ? |
| ACW (ASX) Chart |
Day chart unavailable